SEARCH

SEARCH BY CITATION

REFERENCES

  • Anayama, T., Furihata, M., Ishikawa, T., Ohtsuki, Y. and Ogoshi, S., Positive correlation between p27Kip1 expression and progression of human esophageal squamous cell carcinoma. Int. J. Cancer, 79, 439-443 (1998).
  • Catzavelos, C., Tsao, M.S., Deboer, G., Bhattacharya, N., Shepherd, F.A. and Slingerland, J.M., Reduced expression of the cell cycle inhibitor p27Kip1 in non-small cell lung carcinoma: a prognostic factor independent of Ras. Cancer Res., 59, 684-688 (1999).
  • Cote, R.J., Shi, Y., Groshen, S., Feng, A.C., Cordon-cardo, C., Skinner, D. and Lieskovosky, G., Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma. J. Nat. Cancer Inst., 90, 916-920 (1998).
  • Esposito, V., Baldi, A., de Luca, A., Groger, A.M., Loda, M., Giordano, G.G., Caputi, M., Baldi, F., Pagano, M. and Giordano, A., Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res., 57, 3381-3385 (1997).
  • Fero, M.L., Randel, E., Gurley, K.E., Roberts, J.M. and Kemp, C.J., The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature (Lond.), 396, 177-180 (1998).
  • Fredersdorf, S. and 13 Others, High level expression of p27kip1 and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27kip1 and degree of malignancy in human breast and colorectal cancers. Proc. at. Acad. Sci. (Wash.), 94, 6380-6385 (1997).
  • Fujieda, S., Inuzuka, M., Tanaka, N., Sunaga, H., Fan, G.K., Ito, T., Sugimoto, C., Tsuzuki, H. and Saito, H., Expression of p27 is associated with Bax expression and spontaneous apoptosis in oral and oropharyngeal carcinoma. Int. J. Cancer, 84, 315-320 (1999).
  • Glaise, D., Ilyin, G.P., Loyer, P., Cariou, S., Bilodeau, M., Lucas, J., Puisieux, A., Ozturk, M. and Guguen-Guillouzo, C., Cell cycle gene regulation in reversibly differentiated new human hepatoma cell lines. Cell Growth Differentiation, 9, 165-176 (1998).
  • Hengst, L. and Reed, S.I., Translational control of p27Kip1 accumulation during the cell cycle. Science, 271, 1861-1864 (1996).
  • Ishak, T. (ed.), Histological typing of tumours of the liver, Springer-Verlag, New York (1994).
  • Ito, Y. and 14 Others, Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Hepatology, 30, 90-99 (1999).
  • Kawamata, N. and 12 Others, Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res., 55, 2266-2269 (1995).
  • Ladha, M.H., Lee, K.Y., Upton, T.M., Reed, M.F. and Ewen, M.E., Regulation of exit from quiescence by p27 and cyclin D1-CDK4. Mol. Cell. Biol., 18, 6605-6615 (1998).
  • Lloyd, R.V., Erickson, L.A., Jin, L., Kulig, E., Qian, X., Cheville, J.C. and Scheithauer, B.W., p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Amer. J. Pathol., 154, 313-323 (1999).
  • Loda, M., Cukor, B., Tam, S.W., Lavin, P., Fiorentino, M., Draetta, G.F., Jessup, J.M. and Pagano, M., Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature (Med.), 3, 231-234 (1997).
  • Mori, M., Mimori, K., Shiraishi, T., Tanaka, S., Ueo, H., Sugimachi, K. and Akiyoshi, T., p27 expression and gastric carcinoma. Nature (Med.), 3, 593 (1997).
  • Nurse, P., The Josef Steiner Lecture. CDKs and cell-cycle control in fission yeast: relevance to other eukaryotes and cancer. Int. J. Cancer, 71, 707-708 (1997).
  • Ohtani, M., Isozaki, H., Fujii, K., Nomura, E., Niki, M., Mabuchi, H., Nishiguchi, K., Toyoda, M., Ishibashi, T. and Tanigawa, N., Impact of the expression of cyclin-dependent kinase inhibitor p27Kip1 and apoptosis in tumor cells on the overall survival of patients with non-early stage gastric carcinoma. Cancer, 85, 1711-1718 (1999).
  • Qin, L.F., Ng, I.O., Fan, S.T. and Ng, M., p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma. Int. J. Cancer, 79, 424-428 (1998).
  • Santoni-Rugiu, E., Jensen, M.R., Factor, V.M. and thorgeirsson, S.S., Acceleration of c-myc-induced hepatocarcinogenesis by co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption. Amer. J. Pathol., 154, 1693-1700 (1999).
  • Singh, S.P., Lipman, J., Goldman, H., Ellis, F.H. Jr., Aizenman, L., Cangi, M.G., Signoretti, S., Chiaur, D.S., Pagano, M. and Loda, M., Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res., 58, 1730-1735 (1998).
  • Sobin, L.H. and Wittekind, Ch. (eds.), TNM classification of malignant tumors, 5th ed., Wiley-Liss, New York (1997).
  • Spirin, K.S., Simpson, J.F., Takeuchi, S., Kawamata, N., Miller, C.W. and Koeffler, H.P., p27/Kip1 mutation found in breast cancer. Cancer Res., 56, 2400-2404 (1996).
  • Tan, P., Cady, B., Wanner, M., Worland, P., Cukor, B., Magi-Galluzzi, C., Lavin, P., Draetta, G., Pagano, M. and Loda, M., The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Cancer Res., 57, 1259-1263 (1997).
  • Tannapfel, A., Engeland, K., Weinans, L., Katalinic, A., Hauss, J., Moessner, J. and Wittekind, Ch., Expression of p73, a novel protein related to the p53 tumour suppressor, and apoptosis in cholangiocellular carcinoma of the liver. Brit. J. Cancer, 80, 1069-1074 (1999).
  • Tannapfel, A., Wasner, M., Krause, K., Geissler, F., Katalinic, A., Hauss, J., Moessner, J., Engeland, K. and wittekind, Ch., Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma. J. Nat. Cancer. Inst., 91, 154-158 (1999).
  • Thomas, G.V., Szigeti, K., Murphy, M., Draetta, G., Pagano, M. and Loda, M., Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Amer. J. Pathol., 153, 681-687 (1998).
  • Tsihlias, J., Kapusta, L. and Slingerland, J., The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Ann. Rev. Med., 50, 401-423 (1999).
  • Wang, X., Gorospe, M., Huang, Y. and Holbrook, N.J., p27Kip1 overexpression causes apoptotic death of mammalian cells. Oncogene, 15, 2991-2997 (1997).
  • Wittekind, Ch. Hepatocellular carcinoma. In: P.Hermanek, M.K.Gospodarowicz, D.E.Henson, R.V.P.Hutter, and L.H.Sobin (eds.), Prognostic factors in cancer, pp. 88-94, Springer-Verlag, New York 1995).